Bottom line
What is VMAVX's expense ratio?
VMAVX's expense ratio is 0.5%, or about $50 a year on every $10,000 invested. That is cheaper than 87% of allocation / balanced funds we track (median 0.91%). Its expense ratio includes a 0.3% 12b-1 marketing fee.
Updated Sep 3, 2026
VMAVX fee table
| Net expense ratio | 0.5% |
|---|---|
| Gross expense ratio | 1.21% |
| Management fee | 0.05% |
| 12b-1 (distribution) fee | 0.3% |
| Other expenses | 0.14% |
| Acquired fund fees | 0.72% |
| Fee waiver / reimbursement | -0.71% |
Source: Fund prospectus fee table, filed Sep 3, 2026
What VMAVX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| VMAVX | $123 | $384 | $665 | $1,466 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.5% expense ratio costs roughly $28,900 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).